Rhythm Pharmaceuticals (RYTM) PT Raised to $50 at Stifel
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $115.48 -0.47%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Dae Gon Ha raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $50.00 (from $44.00) while maintaining a Buy rating.
You May Also Be Interested In
- UK regulator expands Imcivree approval to hypothalamic obesity
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
